Biopharmacopae Inks $2M in Venture Financing

Biopharmacopae Design International Inc., a company focused on plant-derived ingredients and products for the "nutraceutical" and "cosmeceutical" industries, has raised $2 million in new financing. Canadian venture capital firm Avrio Ventures provided the second round, which will help the company commercialize its flagship cough and cold remedy.

22 February 2011•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail